权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Integration of early genetic alterations and inflammation in gastroesophageal premalignancy

胃食管癌前病变中早期基因改变和炎症的整合

基本信息

批准号：
10559661
负责人：
Nilay Sethi
金额：
$ 15.8万
依托单位：
DANA-FARBER CANCER INST
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-04-01 至 2024-01-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10559661
关键词：
Acceleration Advisory Committees Basic Science Bass Cancer Biology Career Choice Cell Culture System Cell physiology Cells Cellular biology Chronic Clinical Collaborations Complement Coupled DNA Sequence Alteration Dana-Farber Cancer Institute Data Dedications Development Disease Enabling Factors Environment Esophagogastric Junction Evolution Experimental Designs Experimental Models Exposure to Feedback Fluorescent Probes Gastroesophageal reflux disease Gastrointestinal Diseases Gastrointestinal tract structure Genetic Genetically Engineered Mouse Genomics Goals Growth Human In Vitro Inflammation Inflammation Mediators Inflammatory Inflammatory Response Institution Interleukin-1 beta LGR5 gene Label Laboratories Laboratory Research Lesion Malignant Neoplasms Mediating Mediator Medical Oncologist Mentors Mentorship Methods Modeling Molecular Molecular Biology Mutate Mutation Neoplasms Organoids Pathway interactions Patients Positioning Attribute Precancerous Conditions Prevention strategy Production Program Development Research Research Personnel Research Proposals Risk Factors Sampling System TP53 gene Testing Therapeutic Training Translational Research Work cancer genomics cancer prevention career development clinical risk cytokine design exome sequencing experimental study gastroesophageal cancer in vivo in vivo Model innovation insight mRNA sequencing mouse model mutant novel premalignant research and development screening stem cells tenure track tumor-immune system interactions

项目摘要

PROJECT SUMMARY Chronic inflammation in the gastrointestinal tract promotes the development of premalignant lesions imbued with potential devastating consequences. Defining the precise molecular mediators that collaborate with inflammation to endorse premalignancy will inform the design of effective prevention strategies. Genomic annotation of premalignant gastroesophageal (GE) lesions revealed that TP53 mutations occur frequently and predict the progression to cancer. Based on these observations, we hypothesize that chronic inflammation provides a selective advantage for GE cells harboring TP53 mutations to generate premalignant disease. The objective of this mentored research career development proposal is to combine our recent findings in cancer genomics with novel mouse models of inflammation to derive new conceptual insights into the premalignant state. To this end, we have designed an experimental system that integrates TP53 alterations in GE cells with two modes of inflammation using a novel mouse model (Aim 1). By labeling TP53 mutant GE cells with fluorescent probes, we will be able to track the evolution of premalignant disease in the setting of inflammation. Furthermore, direct analysis of premalignant lesions from these studies will help elucidate specific mutations and/or pathways that enable a selective advantage for TP53 mutant GE cells. We will also utilize an in vitro system to systematically test the impact of disease-relevant inflammation-associated factors on cellular functions of TP53 altered GE cells (Aim 2). Our preliminary data showed that deletion of TP53 in premalignant GE cells stimulates the production of inflammatory cytokines, implicating a potential vicious feedback cycle. Using a complement of mouse models, organoid culture, and patient samples, we will investigate the functional significance of inflammation pathways induced by TP53 alterations in premalignant GE lesions (Aim 3). Overall, these studies hold tremendous promise for cancer prevention in GE premalignancy. I am a medical oncologist with a research background in cellular and molecular biology. My long-term goal is to become a tenure-track independent laboratory investigator with expertise in gastrointestinal diseases. I am dedicated to leading a basic and translational research laboratory that defines key functional mechanisms of premalignant gastrointestinal disease with an emphasis on inflammation, genomics, and therapeutics. During my proposed training period, I will perform mentored research in the laboratory of Dr. Adam Bass at the Dana-Farber Cancer Institute. I am fortunate to have an exceptional advisory committee to help guide my research and career development including Dr. William Kaelin, Dr. Benjamin Ebert, Dr. Timothy Wang, Dr. Anil Rustgi, and Dr. Kevin Haigis. Coupled with an outstanding institutional environment, training plan, and career development program, the proposed research will enable me to achieve my long-term career aspirations.

项目总结

项目成果

期刊论文数量（5）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Replicative stress in gastroesophageal cancer is associated with chromosomal instability and sensitivity to DNA damage response inhibitors.

DOI：
10.1016/j.isci.2023.108169
发表时间：
2023-11-17
期刊：
ISCIENCE
影响因子：
5.8
作者：
Sahgal, Pranshu;Patil, Deepa T.;Bala, Pratyusha;Sztupinszki, Zsofia M.;Tisza, Viktoria;Spisak, Sandor;Luong, Anna G.;Huffman, Brandon;Prosz, Aurel;Singh, Harshabad;Lazaro, Jean-Bernard;Szallasi, Zoltan;Cleary, James M.;Sethi, Nilay S.
通讯作者：
Sethi, Nilay S.

Truncating SOX9 Alterations Are Heterozygous Null Alleles in Genome-Stable Colorectal Cancer.